{
    "document_name": "ung-thu-vu-giai-doan-2.json",
    "document_name_accent": "ung thu vu giai doan 2.json",
    "document_title": "Stage 2 breast cancer: Symptoms, treatment and prognosis",
    "document_category": "Oncology",
    "subsection_name": "ung-thu-vu-giai-doan-2.json_4_Follow-up care after stage II breast cancer treatment",
    "subsection_content": "After completing treatment, patients need to be followed for at least 5 years by oncologists. The follow-up schedule is usually every 3-4 months for the first 2-3 years, then every 4-6 months for the next 2-3 years. This follow-up schedule is not fixed for all patients, but can be adjusted depending on the risk level and health factors of each patient. During this time, patients with indications for supportive endocrine therapy (ER PR positive endocrine receptor) continue to maintain medication use.\nParaclinical examinations during the follow-up period (blood tests, breast ultrasound, mammography, whole body bone mineral density measurement, gynecological examination, chest X-ray, CT or PET-CT...) may be performed. will be prescribed differently for each patient, depending on factors such as disease stage, breast cancer treatments that have been and are being performed, health status, age, menopause, etc.\nFor example:\nPatients who have breast-conserving surgery and breast radiation therapy should have screening mammograms every year, starting 6-12 months after the end of radiation therapy. Patients receiving supportive treatment with Tamoxifen should have a gynecological examination at least once a year.\nFor patients who have completed treatment, it is necessary to monitor their health to detect unusual signs and symptoms early. When experiencing any concerns, patients should go to the hospital as soon as possible.\nAfter completing treatment for stage II breast cancer, patients continue to be monitored by doctors for at least 5 years.",
    "subsection_title": "ung thu vu giai doan 2.json. Follow-up care after stage II breast cancer treatment",
    "subsection_data": "ung thu vu giai doan 2.json. Follow-up care after stage II breast cancer treatment\nAfter completing treatment, patients need to be followed for at least 5 years by oncologists. The follow-up schedule is usually every 3-4 months for the first 2-3 years, then every 4-6 months for the next 2-3 years. This follow-up schedule is not fixed for all patients, but can be adjusted depending on the risk level and health factors of each patient. During this time, patients with indications for supportive endocrine therapy (ER PR positive endocrine receptor) continue to maintain medication use.\nParaclinical examinations during the follow-up period (blood tests, breast ultrasound, mammography, whole body bone mineral density measurement, gynecological examination, chest X-ray, CT or PET-CT...) may be performed. will be prescribed differently for each patient, depending on factors such as disease stage, breast cancer treatments that have been and are being performed, health status, age, menopause, etc.\nFor example:\nPatients who have breast-conserving surgery and breast radiation therapy should have screening mammograms every year, starting 6-12 months after the end of radiation therapy. Patients receiving supportive treatment with Tamoxifen should have a gynecological examination at least once a year.\nFor patients who have completed treatment, it is necessary to monitor their health to detect unusual signs and symptoms early. When experiencing any concerns, patients should go to the hospital as soon as possible.\nAfter completing treatment for stage II breast cancer, patients continue to be monitored by doctors for at least 5 years."
}